ALAMEDA, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that it has scheduled a Special Meeting of Stockholders as requested by Biotechnology Value Fund, L.P. (BVF). Information about the meeting can be found in Avigen’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 9, 2009 and mailed to stockholders on March 10, 2009.
